Christine Berni Silverstein Marinus Pharmaceuticals, Inc. (MRNS) insider trading activity

Christine Berni Silverstein is Director of MARINUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of MRNS, which is worth approximately $0. The most recent transaction as insider was on Feb 11, 2025, when has been sold 4,702 shares (Common Stock) at a price of $0.55 per share, resulting in proceeds of $2,586. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Christine Berni Silverstein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 11 2025	SELL Sale (or disposition) back to the issuer	$2,586 $0.55 p/Share	4,702 Reduced 100.0%	0 Common Stock
Feb 07 2025	SELL Sale (or disposition) back to the issuer	$5,168 $0.55 p/Share	9,398 Reduced 66.65%	4,702 Common Stock
Jun 18 2024	BUY Grant, award, or other acquisition	-	2,300 Added 14.02%	14,100 Common Stock
Jan 18 2024	BUY Grant, award, or other acquisition	-	4,600 Added 28.05%	11,800 Common Stock
Jan 26 2023	BUY Grant, award, or other acquisition	-	7,200 Added 50.0%	7,200 Common Stock

Also insider at

ABEO

ABEONA THERAPEUTICS INC. Healthcare

Director

CBS